Advertisement

Ads Placeholder
Loading...

Phibro Animal Health Corporation

PAHCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$55.52
$0.76(1.39%)
U.S. Market opens in 0h 57m

Phibro Animal Health Corporation (PAHC) Stock Overview

Explore Phibro Animal Health Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.3B
P/E Ratio24.44
EPS (TTM)$2.26
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$56.79
3 Months$54.76
1 Year Target$62.69

PAHC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Phibro Animal Health Corporation (PAHC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 59.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $62.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 24.44 and a market capitalization of 2.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.39%
5-Day Change
0.51%
1-Month Change
6.22%
3-Month Change
48.85%
6-Month Change
44.89%
Year-to-Date (YTD) Change
48.85%
1-Year Change
174.58%
3-Year Change
266.71%
5-Year Change
121.11%
All-Time (Max) Change
226.59%

Contact Information

201 329 7300
Glenpointe Centre East, Teaneck, NJ, 07666-6712

Company Facts

19,400 Employees
IPO DateApr 11, 2014
CountryUS
Actively Trading

Frequently Asked Questions